Microbot Medical Inc.
NASDAQ:MBOTMedical - Instruments & Supplies
-$0.06 today
- Market cap
- $65.73M
- Beta
- 1.04
- P/E (TTM)
- -8.6
- EPS (TTM)
- -$0.21
Volume 0.87M
Average 1.60M
MBOT Other Current Liabilities
Short-term obligations not reported separately, such as accrued expenses.
Microbot Medical Inc.NASDAQ: MBOT
Other Current Liabilities · Q1 FY2026 · quarter ended Mar 2026
Other current liabilities remains negative
Q1 FY2026 other current liabilities was $1.98M, compared with $0 a year earlier. Over 3 fiscal years it compounded at +88.1% a year.
Context
- Other current liabilities amounted to 2.5% of total assets at the end of Q1 FY2026, up 2.5 pp from a year earlier.
- Other current liabilities increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
Sources:Balance SheetText generated from reported figures; not investment advice.
Other Current Liabilities history
USD · from the balance sheet
- Latest · FY2025
- 1.98M USD
- Year-over-year change
- +40.3%
| Period | Period end | Other Current Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 1.98M | +40.3% |
| FY2024 | 2024-12-31 | 1.41M | +75.9% |
| FY2023 | 2023-12-31 | 804K | +169.8% |
| FY2022 | 2022-12-31 | 298K | — |
| FY2021 | 2021-12-31 | 0 | — |
Other Current Liabilities vs competitors
How MBOT compares with its peers on the latest reported figures
- Peers report in different currencies, so other current liabilities is compared through growth and share of total assets rather than absolute size.
- Other current liabilities amounts to 2.5% of total assets for MBOT, versus a peer median of 8.5%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $29.3M USD | +8.4% | -21.5% | 14.0% | |
| Mar 2026 | $13.31M USD | +124.4% | +178.1% | 25.8% | |
| Mar 2026 | CA$7.11M CAD | +781651045104510592.0% | +75.7% | 22.6% | |
| Mar 2026 | $5.41M USD | — | — | 2.4% | |
| Mar 2026 | $3.23M USD | +286.1% | — | 1.2% | |
| Mar 2026 | $2.03M USD | — | +28.2% | 9.4% | |
| Mar 2026 | $1.98M USD | — | +88.1% | 2.5% | |
| Mar 2026 | CA$1.28M CAD | — | +10757.8% | 8.5% | |
| Mar 2026 | $509.4K USD | +61.7% | +18.6% | 0.9% | |
| Mar 2026 | $349K USD | -0.3% | -1.8% | 0.8% | |
| Peer median (excluding MBOT) | — | +93.0% | +28.2% | 8.5% | |
Competitors are the stored peer set for MBOT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Microbot Medical Inc.
NASDAQ:MBOT
Intrinsic Alpha fair value
Locked
Current Price
$0.98
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.